Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.020 | 1.150 | 0.130 |
Stocks | 96.980 | 96.980 | 0.000 |
Other | 2.000 | 2.140 | 0.140 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 15.117 | 14.358 |
Price to Book | 2.442 | 2.000 |
Price to Sales | 1.593 | 1.332 |
Price to Cash Flow | 10.718 | 8.767 |
Dividend Yield | 2.508 | 3.258 |
5 Years Earnings Growth | 9.040 | 9.684 |
Name | Net % | Category Average |
---|---|---|
Industrials | 20.080 | 15.934 |
Healthcare | 17.660 | 14.850 |
Financial Services | 15.030 | 17.290 |
Consumer Cyclical | 13.300 | 10.483 |
Technology | 10.670 | 9.576 |
Consumer Defensive | 8.240 | 11.483 |
Energy | 5.320 | 5.176 |
Basic Materials | 4.740 | 6.873 |
Utilities | 2.780 | 4.451 |
Communication Services | 2.190 | 4.981 |
Number of long holdings: 86
Number of short holdings: 6
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 6.22 | 915.7 | -0.43% | |
ASML Holding | NL0010273215 | 5.00 | 896.00 | +1.52% | |
Louis Vuitton | FR0000121014 | 3.58 | 745.40 | -1.43% | |
AstraZeneca | GB0009895292 | 3.42 | 12,028.0 | -2.18% | |
Schneider Electric | FR0000121972 | 3.13 | 232.70 | -0.62% | |
Shell | GB00BP6MXD84 | 3.08 | 32.80 | -0.15% | |
Hermes International | FR0000052292 | 2.32 | 2,180.00 | -0.91% | |
L'Oreal | FR0000120321 | 2.13 | 445.65 | -0.82% | |
Sanofi | FR0000120578 | 2.11 | 88.58 | -1.42% | |
Iberdrola | ES0144580Y14 | 2.07 | 12.150 | -0.41% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
IE00B1W57P38 | 380.78M | -5.79 | -3.93 | 3.98 | ||
Principal Global Investors Funds EA | 171.97M | 2.32 | 1.68 | 4.06 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review